TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

350.90$ +5.1% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KRYS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.4% 99.6% 97.0% 93.7% 88.5% 70.6% 68.7% 71.8% 70.3% 76.8%
88.1% 99.0% 89.3% 89.7% 86.3% 54.5% 29.0% 43.8% 32.7% 37.2%
88.1% 99.0% 96.2% 92.7% 87.3% 70.0% 67.9% 65.0% 56.6% 62.1%
0.0% 5.1% 9.9% 9.6%
0.0% 0.0% 0.9% 2.5% 3.0%
0.6% 0.4% 2.6% 5.4% 9.9% 19.1% 30.4%
0.0%
0.0%
86.8% 1.3% 2.5% 2.9% 6.0% 5.2% 6.5% 4.9% 10.4% 8.6%
2.0% 1.3% 2.2% 1.6% 5.0% 4.1% 5.2% 4.0% 9.7% 7.7%
0.0% 0.2% 2.7% 0.2% 0.3% 0.2% 0.1% 0.1%
1.9% 0.4% 0.8% 0.5% 0.7% 1.3% 0.7% 0.2% 0.5% 0.2%
84.5% 0.0%
13.2% 98.7% 97.5% 97.1% 94.0% 94.8% 93.5% 95.1% 89.6% 91.4%
-52.7% -18.1% -17.2% -18.7% -22.9% -22.5% -50.3% -33.0% -17.1% 1.8%
195.9% 10.7% 9.6% 7.6% 6.0% 3.5% 4.6% 3.4% 2.8% 2.2%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?